These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12113458)

  • 41. Characterization and partial purification of bovine alpha-lactalbumin and beta-casein produced in milk of transgenic mice.
    Jeng SY; Bleck GT; Wheeler MB; Jiménez-Flores R
    J Dairy Sci; 1997 Dec; 80(12):3167-75. PubMed ID: 9436095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of human coagulation factor VIII in a human hybrid cell line, HKB11.
    Mei B; Chen Y; Chen J; Pan CQ; Murphy JE
    Mol Biotechnol; 2006 Oct; 34(2):165-78. PubMed ID: 17172662
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of transgenesis on rabbit thyroid tissue structure.
    Tvrda E; Massanyi P; Lukac N; Danko J; Chrenek P
    Anat Histol Embryol; 2012 Jun; 41(3):233-6. PubMed ID: 22034963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant factor VIII: past, present and future of treatment of hemophilia A.
    Raso S; Hermans C
    Drugs Today (Barc); 2018 Apr; 54(4):269-281. PubMed ID: 29869648
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression and characterization of a mutant recombinant blood coagulation factor VIII (rFVIII (m)).
    Oh SH; Cho SY; Jin HS; Jeong DL; Jung SG; Oh KH
    Exp Mol Med; 2002 Jul; 34(3):233-8. PubMed ID: 12216115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Production of recombinant human von Willebrand factor in the milk of transgenic pigs.
    Lee HG; Lee HC; Kim SW; Lee P; Chung HJ; Lee YK; Han JH; Hwang IS; Yoo JI; Kim YK; Kim HT; Lee HT; Chang WK; Park JK
    J Reprod Dev; 2009 Oct; 55(5):484-90. PubMed ID: 19521054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transgenic factor VIII: the milky way and beyond.
    Hennighausen L
    Nat Biotechnol; 1997 Oct; 15(10):945-6. PubMed ID: 9335038
    [No Abstract]   [Full Text] [Related]  

  • 48. Therapeutic levels of human factor VIII in mice implanted with encapsulated cells: potential for gene therapy of haemophilia A.
    García-Martín C; Chuah MK; Van Damme A; Robinson KE; Vanzieleghem B; Saint-Remy JM; Gallardo D; Ofosu FA; Vandendriessche T; Hortelano G
    J Gene Med; 2002; 4(2):215-23. PubMed ID: 11933222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Non-viral vector mediating human coagulation factor VIII gene expression in mouse 32D cell line].
    Yin J; Wang HL; Wang XF; Qu B; Wu WM; Ding QL; Fu QH; Qi ZW; Wang ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):721-5. PubMed ID: 15631647
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenotypic correction and stable expression of factor VIII in hemophilia A mice by embryonic stem cell therapy.
    Wang JJ; Kuang Y; Zhang LL; Shen CL; Wang L; Lu SY; Lu XB; Fei J; Gu MM; Wang ZG
    Genet Mol Res; 2013 May; 12(2):1511-21. PubMed ID: 23765957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac mice.
    Gallo-Penn AM; Shirley PS; Andrews JL; Kayda DB; Pinkstaff AM; Kaloss M; Tinlin S; Cameron C; Notley C; Hough C; Lillicrap D; Kaleko M; Connelly S
    Hum Gene Ther; 1999 Jul; 10(11):1791-802. PubMed ID: 10446919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Absence of functional compensation between coagulation factor VIII and plasminogen in double-knockout mice.
    Stagaard R; Ley CD; Almholt K; Olsen LH; Knudsen T; Flick MJ
    Blood Adv; 2018 Nov; 2(22):3126-3136. PubMed ID: 30459211
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bovine alpha S1-casein gene sequences direct high level expression of active human urokinase in mouse milk.
    Meade H; Gates L; Lacy E; Lonberg N
    Biotechnology (N Y); 1990 May; 8(5):443-6. PubMed ID: 1369989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of human alpha-lactalbumin in transgenic tobacco.
    Takase K; Hagiwara K
    J Biochem; 1998 Mar; 123(3):440-4. PubMed ID: 9538226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of improved factor VIII molecules and new gene transfer approaches for hemophilia A.
    Saenko EL; Ananyeva NM; Moayeri M; Ramezani A; Hawley RG
    Curr Gene Ther; 2003 Feb; 3(1):27-41. PubMed ID: 12553533
    [TBL] [Abstract][Full Text] [Related]  

  • 56. OBI-1, porcine recombinant Factor VIII for the potential treatment of patients with congenital hemophilia A and alloantibodies against human Factor VIII.
    Toschi V
    Curr Opin Mol Ther; 2010 Oct; 12(5):617-25. PubMed ID: 20886394
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro characterization of recombinant factor VIII concentrates reveals significant differences in protein content, activity and thrombin activation profile.
    Pahl S; Pavlova A; Driesen J; Müller J; Pötzsch B; Oldenburg J
    Haemophilia; 2013 May; 19(3):392-8. PubMed ID: 23252674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of Adeno-Associated Viral Vector-Mediated Human Factor VIII Gene Therapy in Hemophilia A Mice.
    Greig JA; Wang Q; Reicherter AL; Chen SJ; Hanlon AL; Tipper CH; Clark KR; Wadsworth S; Wang L; Wilson JM
    Hum Gene Ther; 2017 May; 28(5):392-402. PubMed ID: 28056565
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short-term correction of factor VIII deficiency in a murine model of hemophilia A after delivery of adenovirus murine factor VIII in utero.
    Lipshutz GS; Sarkar R; Flebbe-Rehwaldt L; Kazazian H; Gaensler KM
    Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13324-9. PubMed ID: 10557319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficient production of human FVIII in hemophilic mice using lentiviral vectors.
    Kootstra NA; Matsumura R; Verma IM
    Mol Ther; 2003 May; 7(5 Pt 1):623-31. PubMed ID: 12718905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.